Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
INTERCEPT PHARMACEUTICALS, INC. reports $32.1 million Q1 loss
By USInMinutes - Apr 27, 2023, 04:20 PM ET
Last Updated - Jul 18, 2023, 03:48 PM EDT
The company generated $68 million in quarterly revenue
INTERCEPT PHARMACEUTICALS, INC. [ICPT] has reported fiscal Q1 loss of $32.10 million.
Sponsored
On a per-share basis, the DE based company said its diluted earnings are $0.77.
The Pharmaceutical Preparations firm posted revenue of $68 million in this period.
Also Read:
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Read More from Investing
Popular News
Latest News